Abram Scientific
Developer of a portable, rapid viscoelastic blood coagulation diagnostic platform intended for point-of-care use. The company focuses on providing fast, low-volume assays and a wireless handheld meter with single-use test strips to generate viscoelastic curves and coagulation parameters for clinical decision support in surgery, emergency, anticoagulation management, defense, and pharmaceutical contexts.
Industries
Nr. of Employees
small (1-50)
Abram Scientific
400 Oyster Point Blvd Suite #110, South San Francisco, CA 94080
Patents
Products
Portable viscoelastic blood coagulation diagnostic platform
A handheld wireless meter paired with single-use diagnostic strips that produces viscoelastic curves and coagulation parameters from small blood samples for point-of-care use.
Portable viscoelastic blood coagulation diagnostic platform
A handheld wireless meter paired with single-use diagnostic strips that produces viscoelastic curves and coagulation parameters from small blood samples for point-of-care use.
Services
Development of portable viscoelastic coagulation testing systems integrating single-use strips and a wireless handheld meter for rapid, low-volume assays.
Development of portable viscoelastic coagulation testing systems integrating single-use strips and a wireless handheld meter for rapid, low-volume assays.
Expertise Areas
- Coagulation diagnostics
- Point-of-care testing
- Viscoelastic testing and thromboelastography
- Anticoagulant monitoring
Key Technologies
- Viscoelastic measurement methods
- Thromboelastography-style analysis
- Thrombin generation assays
- Wireless handheld diagnostic meters
News & Updates
Company CEO selected to present at LSI 2024 Emerging Medtech Summit in Dana Point, California on March 21, 2024.
Awarded two NSF SBIR Phase IIB and Technology Enhancement for Commercial Partnerships supplemental grants totaling $0.7M.
Raised $2.4M in seed financing to complete product development of the viscoelastometry system.
Secured a $1M National Science Foundation SBIR Phase II grant.
Secured a $2.9M US Army medical research grant to develop a portable viscoelastic blood coagulation diagnostic platform for COVID-19-associated coagulopathy management.
Company CEO selected to present at LSI 2024 Emerging Medtech Summit in Dana Point, California on March 21, 2024.
Awarded two NSF SBIR Phase IIB and Technology Enhancement for Commercial Partnerships supplemental grants totaling $0.7M.
Raised $2.4M in seed financing to complete product development of the viscoelastometry system.
Secured a $1M National Science Foundation SBIR Phase II grant.
Secured a $2.9M US Army medical research grant to develop a portable viscoelastic blood coagulation diagnostic platform for COVID-19-associated coagulopathy management.